Clinical Trial Update: Pain Management With Pecfent in the Prevention of Pain Induced by Position in Radiotherapy [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluating Pecfent for preventing pain caused by positioning during radiotherapy in patients with bone metastasis has completed. The update note…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bone Metastasis

Drugs mentioned

• Pecfent (fentanyl citrate)

Snippet

Sponsor: Centre Henri Becquerel | Conditions: Bone Metastasis | Phase 3 | Status: COMPLETED